Catherine A. Lesyna
About Catherine A. Lesyna
Catherine A. Lesyna is a Bioengineer IV at LMI, where she has worked since 2019, focusing on the development of medical countermeasures against biological and chemical threats. She holds a BS in Animal Science from the University of Delaware and a PhD in Biochemistry from Pennsylvania State University.
Current Role at LMI
Catherine A. Lesyna has been serving as a Bioengineer IV at LMI since 2019. In this role, she is based in APG, MD, and focuses on the development of medical countermeasures aimed at addressing biological and chemical threat agents. Her responsibilities include providing budget, risk, and programmatic support for candidate CBRN drugs, biologics, and devices. Lesyna's work is crucial in advancing the safety and efficacy of medical solutions in response to potential threats.
Previous Experience at Excet, Incorporated
Before her current position, Catherine A. Lesyna worked at Excet, Incorporated as a Consultant from 2018 to 2019. Her tenure lasted for eight months, during which she contributed her expertise in bioengineering. Prior to this consulting role, she served as a Senior Scientist II at Excet from 2015 to 2018, where she worked at the Edgewood Chemical and Biological Center for three years.
Education and Expertise
Catherine A. Lesyna holds a Bachelor of Science degree in Animal Science from the University of Delaware, where she studied from 1995 to 2000. She furthered her education at Pennsylvania State University, earning a PhD in Biochemistry from the Department of Microbiology and Molecular Biology between 2001 and 2009. This educational background provides her with a strong foundation in the biological sciences, which she applies in her current work.
Postdoctoral Research Experience
Lesyna gained valuable research experience as a Postdoctoral Researcher at Pennsylvania State University from 2012 to 2013. During her six-month tenure in the State College, Pennsylvania area, she engaged in advanced scientific research, contributing to her expertise in the field of bioengineering and related disciplines.
Scientific Contributions to CBRN Drugs
In her current role and previous positions, Catherine A. Lesyna provides scientific and technological advice aimed at advancing CBRN prophylactic and therapeutic drugs. Her work supports the FDA licensure process for these drugs, ensuring that they meet regulatory standards and are safe for public use. This aspect of her career highlights her commitment to public health and safety.